Literature DB >> 35108505

Reply to In vivo confusion over in vivo conversion.

Lei-Lei Wang1, Chun-Li Zhang2.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35108505      PMCID： PMC8899670          DOI： 10.1016/j.ymthe.2022.01.027

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  14 in total

1.  The p53 Pathway Controls SOX2-Mediated Reprogramming in the Adult Mouse Spinal Cord.

Authors:  Lei-Lei Wang; Zhida Su; Wenjiao Tai; Yuhua Zou; Xiao-Ming Xu; Chun-Li Zhang
Journal:  Cell Rep       Date:  2016-10-11       Impact factor: 9.423

2.  In vivo reprogramming of NG2 glia enables adult neurogenesis and functional recovery following spinal cord injury.

Authors:  Wenjiao Tai; Wei Wu; Lei-Lei Wang; Haoqi Ni; Chunhai Chen; Jianjing Yang; Tong Zang; Yuhua Zou; Xiao-Ming Xu; Chun-Li Zhang
Journal:  Cell Stem Cell       Date:  2021-03-05       Impact factor: 24.633

3.  Revisiting astrocyte to neuron conversion with lineage tracing in vivo.

Authors:  Lei-Lei Wang; Carolina Serrano; Xiaoling Zhong; Shuaipeng Ma; Yuhua Zou; Chun-Li Zhang
Journal:  Cell       Date:  2021-09-27       Impact factor: 66.850

4.  SOX2 reprograms resident astrocytes into neural progenitors in the adult brain.

Authors:  Wenze Niu; Tong Zang; Derek K Smith; Tou Yia Vue; Yuhua Zou; Robert Bachoo; Jane E Johnson; Chun-Li Zhang
Journal:  Stem Cell Reports       Date:  2015-04-23       Impact factor: 7.765

5.  In vivo conversion of astrocytes to neurons in the injured adult spinal cord.

Authors:  Zhida Su; Wenze Niu; Meng-Lu Liu; Yuhua Zou; Chun-Li Zhang
Journal:  Nat Commun       Date:  2014-02-25       Impact factor: 14.919

6.  AAV cis-regulatory sequences are correlated with ocular toxicity.

Authors:  Wenjun Xiong; David M Wu; Yunlu Xue; Sean K Wang; Michelle J Chung; Xuke Ji; Parimal Rana; Sophia R Zhao; Shuyi Mai; Constance L Cepko
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-04       Impact factor: 11.205

7.  Gene therapy conversion of striatal astrocytes into GABAergic neurons in mouse models of Huntington's disease.

Authors:  Zheng Wu; Matthew Parry; Xiao-Yi Hou; Min-Hui Liu; Hui Wang; Rachel Cain; Zi-Fei Pei; Yu-Chen Chen; Zi-Yuan Guo; Sambangi Abhijeet; Gong Chen
Journal:  Nat Commun       Date:  2020-02-27       Impact factor: 14.919

8.  A NeuroD1 AAV-Based Gene Therapy for Functional Brain Repair after Ischemic Injury through In Vivo Astrocyte-to-Neuron Conversion.

Authors:  Yu-Chen Chen; Ning-Xin Ma; Zi-Fei Pei; Zheng Wu; Fabricio H Do-Monte; Susan Keefe; Emma Yellin; Miranda S Chen; Jiu-Chao Yin; Grace Lee; Angélica Minier-Toribio; Yi Hu; Yu-Ting Bai; Kathryn Lee; Gregory J Quirk; Gong Chen
Journal:  Mol Ther       Date:  2019-09-06       Impact factor: 11.454

9.  Lineage tracing of direct astrocyte-to-neuron conversion in the mouse cortex.

Authors:  Zongqin Xiang; Liang Xu; Minhui Liu; Qingsong Wang; Wen Li; Wenliang Lei; Gong Chen
Journal:  Neural Regen Res       Date:  2021-04       Impact factor: 5.135

10.  Enhancer Analysis Unveils Genetic Interactions between TLX and SOX2 in Neural Stem Cells and In Vivo Reprogramming.

Authors:  Mohammed M Islam; Derek K Smith; Wenze Niu; Sanhua Fang; Nida Iqbal; Guoqiang Sun; Yanhong Shi; Chun-Li Zhang
Journal:  Stem Cell Reports       Date:  2015-11-10       Impact factor: 7.765
View more
  2 in total

Review 1.  In vivo glia-to-neuron conversion: pitfalls and solutions.

Authors:  Lei-Lei Wang; Chun-Li Zhang
Journal:  Dev Neurobiol       Date:  2022-05-23       Impact factor: 3.102

2.  Parkinson's disease motor symptoms rescue by CRISPRa-reprogramming astrocytes into GABAergic neurons.

Authors:  Jessica Giehrl-Schwab; Florian Giesert; Benedict Rauser; Chu Lan Lao; Sina Hembach; Sandrine Lefort; Ignacio L Ibarra; Christina Koupourtidou; Malte Daniel Luecken; Dong-Jiunn Jeffery Truong; Judith Fischer-Sternjak; Giacomo Masserdotti; Nilima Prakash; Jovica Ninkovic; Sabine M Hölter; Daniela M Vogt Weisenhorn; Fabian J Theis; Magdalena Götz; Wolfgang Wurst
Journal:  EMBO Mol Med       Date:  2022-04-04       Impact factor: 14.260
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.